Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apremilast in Moderate Plaque Psoriasis (UNVEIL)
NCT02425826Phase 4Completed
- Sponsor
- Amgen
- Start
- Apr 2015
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of apremilast in plaque psoriasis, sponsored by Amgen. Started Apr 2015; status: completed.
02
Drugs
apremilast
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT02425826.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02425826.